The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125039122 12503912 2 F 20160615 20160629 20160628 20160706 EXP MX-009507513-1606MEX012333 MERCK 54.00 YR F Y 66.00000 KG 20160706 CN MX MX

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125039122 12503912 1 PS PEGINTERFERON ALFA-2B PEGINTERFERON ALFA-2B 1 Subcutaneous 0.5 ML, QW (STRENGTH: 100 MCG) 103949 .5 ML POWDER FOR INJECTION /wk
125039122 12503912 2 SS COTRONAK RIBAVIRIN 1 Oral 200 MG, 5 TIMES PER DAY 0 200 MG CAPSULE
125039122 12503912 3 C SPIRONOLACTONE. SPIRONOLACTONE 1 Oral 200 MG, PERMANET U 0 200 MG TABLET
125039122 12503912 4 C VITAMIN B COMPLEX CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX 1 Oral 1 TABLET, FOR 1 MONTH U 0 1 DF TABLET
125039122 12503912 5 C PLANTAGO ARENARIA 2 Oral 2 SPOONS PRN U 0 POWDER

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125039122 12503912 1 Hepatitis C
125039122 12503912 2 Hepatitis C
125039122 12503912 3 Ascites
125039122 12503912 4 Vitamin supplementation
125039122 12503912 5 Constipation

Outcome of event

Event ID CASEID OUTC COD
125039122 12503912 OT
125039122 12503912 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125039122 12503912 Abdominal pain upper
125039122 12503912 Arthralgia
125039122 12503912 Asthenia
125039122 12503912 Hepatic encephalopathy
125039122 12503912 Pyrexia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125039122 12503912 1 20160517 0
125039122 12503912 2 20160517 0
125039122 12503912 3 20160622 0
125039122 12503912 4 20160622 0
125039122 12503912 5 20160622 0